Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO) Olaf PenackCarolin BeckerHelmut Ostermann Review Article Open access 29 April 2014 Pages: 1083 - 1095
Relapse assessment following allogeneic SCT in patients with MDS and AML Maximilian ChristopeitNicolaus KrögerUlrike Bacher Review Article 27 March 2014 Pages: 1097 - 1110
G-CSF induces the release of the soluble form of LR11, a regulator of myeloid cell mobilization in bone marrow Naomi ShimizuChiaki NakasekoHideaki Bujo Original Article 28 February 2014 Pages: 1111 - 1122
Influence of the βs haplotype and α-thalassemia on stroke development in a Brazilian population with sickle cell anaemia Igor F. DomingosDiego A. FalcãoMarcos A. Bezerra Original Article 04 February 2014 Pages: 1123 - 1129
The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients Hala AghaMona El TaguiMarwa Abdel Hady Original Article 22 February 2014 Pages: 1131 - 1138
Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy Sylvia T. SingerFrans KuypersElliott P. Vichinsky Original Article 28 February 2014 Pages: 1139 - 1148
Predictive role of minimal residual disease and log clearance in acute myeloid leukemia: a comparison between multiparameter flow cytometry and Wilm’s tumor 1 levels Giovanni RossiMaria Marta MinerviniNicola Cascavilla Original Article 20 February 2014 Pages: 1149 - 1157
Application of the optimized CO-rebreathing method for determination of hemoglobin mass in patients with polycythemia vera C. AhlgrimY. O. SchumacherT. Pottgiesser Original Article 01 February 2014 Pages: 1159 - 1165
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV Ulrike ProetelNadine Pletschfor the German Chronic Myeloid Leukemia Study Group, and the Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK). Original Article Open access 22 March 2014 Pages: 1167 - 1176
Inhibitor of differentiation 1 is a candidate prognostic marker in multicentric Castleman’s disease Chao LiuYi Ran LiuFeng Cai Wei Original Article 06 March 2014 Pages: 1177 - 1183
Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma Aiko KatoYukihiro ImaiTakayuki Ishikawa Original Article 14 February 2014 Pages: 1185 - 1191
Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy Chan Y. CheahMichael DickinsonJohn F. Seymour Original Article 05 March 2014 Pages: 1193 - 1200
Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome Chen WangWei SuJian Li Original Article 31 January 2014 Pages: 1201 - 1206
The lymphoma-like polychemotherapy regimen “Dexa-BEAM” in advanced and extramedullary multiple myeloma Leo RascheSusanne StriflerStefan Knop Original Article 14 February 2014 Pages: 1207 - 1214
Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases Ryo NasuYasuhito NannyaMineo Kurokawa Original Article 04 March 2014 Pages: 1215 - 1223
Palonosetron versus first-generation 5-hydroxytryptamine type 3 receptor antagonists for emesis prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation Cheng-Wei ChouYeh-Ku ChenChieh-Lin Jerry Teng Original Article 07 March 2014 Pages: 1225 - 1232
Successful management of acute myeloid leukemia transformed from myelodysplastic syndromes in an elderly patient aged over 80 years old by ultralow dose decitabine combined with amifostine and autologous CIK cells Bo YangHai-tao WangXue-chun Lu Letter to the Editor 16 November 2013 Pages: 1233 - 1235
Plasma cell myeloma with mature lymphoproliferative disease-like morphology: an unusual case Evdoxia GounariTriantafyllia KoletsaVasiliki Tsavdaridou Letter to the Editor 22 November 2013 Pages: 1237 - 1238
Social correlates of clotting disorders in adults and the very old: UK Understanding Society cohort, 2009–2010 Ivy Shiue Letter to the Editor 15 November 2013 Pages: 1239 - 1241
New perspectives of iron deficiency as a risk factor for ischemic stroke Lenise Jihe KimFernando Morgadinho CoelhoMonica Levy Andersen Letter to the Editor 15 November 2013 Pages: 1243 - 1244
Sustained remission and reversal of end-organ dysfunction in a patient with anaplastic myeloma Mridul AgrawalJennifer KanakryNilanjan Ghosh Letter to the Editor 15 November 2013 Pages: 1245 - 1246
Large granular lymphocytic leukemia of gamma–delta T cells: cytogenetics and fluorescence in situ hybridization study Edmond S. K. MaThomas S. K. WanJoyce C. W. Chan Letter to the Editor 15 November 2013 Pages: 1247 - 1250
A rare IgM multiple myeloma with aberrant PAX5 expression mimicking lymphoplasmacytic lymphoma Z. XuR. Van Der JagtM. Beaulieu Bergeron Letter to the Editor 16 November 2013 Pages: 1251 - 1252
Pleural decortication of a marginal zone lymphoma Thomas MelchardtLukas WeissAlexander Egle Letter to the Editor 22 November 2013 Pages: 1253 - 1254
Clonal multicentric Castleman’s disease with increased free kappa light chains in a patient with systemic lupus erythematosus Matthijs OyaertElke BooneDries Deeren Letter to the Editor 19 November 2013 Pages: 1255 - 1257
Intravascular large B cell lymphoma presenting as cholecystitis: diagnostic challenges persist Siddhartha YadavMohammad Muhsin ChistiMichael A Barnes Letter to the Editor 28 November 2013 Pages: 1259 - 1260
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome Laura De PaduaLuca LaurentiSimona Sica Letter to the Editor 05 December 2013 Pages: 1261 - 1262